膀胱浸润性移行细胞乳头状癌综合治疗疗效观察  

The curative effects of synthesis treatment in patients with invasive bladder transitional cell papillocarcinoma.

作　　者：段国兰 白淑芳 史庭恺 秦大山 段建敏 刘国栋 陈天铎 

机构地区：[1]兰医二院泌尿外科 [2]甘肃省兰州急救中心

出　　处：《甘肃医药》1995年第2期69-70,4-5,共2页Gansu Medical Journal

摘　　要：报告58例慢润性膀胱癌.其中52例采用膀胱部分切除手术方法,3例行膀胱部分切除并患侧输尿管膀胱再吻合,3倒行患侧肾、输尿管、膀胱部分切除.手术后膀胱内科灌注卡介苗(BCG免疫治疗)或噎替哌(ThiotePa)、丝裂素(MMC)化疗.随访结果:复发 7例(12％),木后 2～4年死亡 3例(5.2％),余 55例(94.8％)均存活至今.认为对浸润性膀胱癌施行膀胱部分切除、术后采用免疫疗法与化疗综合治疗,不仅能有效地保留膀胱,使其维持自身的生理功能,而且能成功地进行抗肿瘤免疫治疗与化疗,降低复发率、提高生存率.Partial cystectomy and partial cystecto-my plus ureterocystanastomosis were performed in patients with invasive bladder carcinoma in 52 of 58 and 3 of 58,respectively.Three of 58 received the operation of rephectomy,ureterectomy and partial cystectomy.The BCG or thiotepa or MMC was given intravesically after operations.The follow-up showed that 7 cases recurred (12%).3 died 2 to 4 years after operation (5.2%) and the others were alive up to now.The results suggested that for the invasive bladder carcinoma,partial cystectomy combined with postoperative im-munotherapy and chemotherapy is an effective method.Not only can both the anatomy and physiological function of the bladder be reserved,the recurrent rate be reduced and the survival rate be increased by the effective postoperative antitumor immunothera-py and chemotherapy reatment.

关 键 词：膀胱 转移细胞癌 免疫疗法 膀胱肿瘤 

分 类 号：R737.140.5[医药卫生—肿瘤]